(Q34179500)

31 July 2017

title

Adjunctive gabapentin in treatment-resistant depression: a retrospective chart review (English)

1 reference

treatment-resistant depression

31 July 2017

0 references

1 reference

S Yasmin

1

1 reference

31 July 2017

L L Carpenter

2

1 reference

31 July 2017

Z Leon

3

1 reference

31 July 2017

J M Siniscalchi

4

1 reference

31 July 2017

L H Price

5

1 reference

31 July 2017

publication date

1 March 2001

1 reference

Journal of Affective Disorders

31 July 2017

published in

1 reference

31 July 2017

volume

63

1 reference

31 July 2017

issue

1-3

1 reference

31 July 2017

page(s)

243-247

1 reference

Gabapentin for treatment of bipolar and schizoaffective disorders

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

3-substituted GABA analogs with central nervous system activity: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

Changes in body weight with chronic, high-dose gabapentin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

An open label study of gabapentin in the treatment of acute mania.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

Gabapentin treatment of mood disorders: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

Weight gain and gabapentin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

Field trial of the Global Assessment of Functioning Scale--Modified.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

Gabapentin augments whole blood serotonin in healthy young men

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

Gabapentin in the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

Treatment of acute mania with gabapentin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

Acute treatment of bipolar depression with gabapentin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

Gabapentin as an adjunctive treatment in bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900187-7

7 January 2021

10.1016/S0165-0327(00)00187-7

Identifiers

DOI

1 reference

release_x3xyyav3frczlnbqfxog2ynjb4

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/x3xyyav3frczlnbqfxog2ynjb4

24 November 2022

mapped directly with Wikidata item

1 reference